ECSP982443A - COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION - Google Patents

COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Info

Publication number
ECSP982443A
ECSP982443A ECSP982443A ECSP982443A EC SP982443 A ECSP982443 A EC SP982443A EC SP982443 A ECSP982443 A EC SP982443A EC SP982443 A ECSP982443 A EC SP982443A
Authority
EC
Ecuador
Prior art keywords
compositions
methods
prostaglandin
intraocular pressure
reduce eye
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Shau-Fong Yen
Warren Reed Kenneth
Mary Sou
Regina Flinn Peacock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982443 priority Critical patent/ECSP982443A/en
Publication of ECSP982443A publication Critical patent/ECSP982443A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición oftálmica mejorada, que incluye agentes activos de prostaglandina, la cual es especialmente útil para bajar la presión intraocular asociada con glaucoma. Se logran mejoras en la eficacia de reducción de la presión intraocular, en la eficacia del conservador, y concentraciones de aditivo reducidas, mediante la utilización de las composiciones dadas a conocer, las cuales incluyen un agente activo de prostaglandina (por ejemplo, isopropil-unoprostona, un metabolito de una prostaglandina de la serie F), en conjunto con tensoactivos no iónicos seleccionados, conservadores y agentes de ajuste de tonicidad no iónicos.An improved ophthalmic composition, including prostaglandin active agents, which is especially useful in lowering the intraocular pressure associated with glaucoma. Improvements in intraocular pressure reduction efficacy, preservative efficacy, and reduced additive concentrations are achieved through the use of the disclosed compositions, which include a prostaglandin active agent (eg, isopropyl-unoprostone , a metabolite of a prostaglandin series F), in conjunction with selected nonionic surfactants, preservatives, and nonionic tonicity adjusting agents.

ECSP982443 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION ECSP982443A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Publications (1)

Publication Number Publication Date
ECSP982443A true ECSP982443A (en) 1999-01-05

Family

ID=42043365

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Country Status (1)

Country Link
EC (1) ECSP982443A (en)

Similar Documents

Publication Publication Date Title
MY122237A (en) Compositions and methods for reducing ocular hypertension
MX9405006A (en) OPHTHALMIC SOLUTION FOR ARTIFICIAL TEARS.
BR0013255A (en) Tear replacement agent
AR052252A1 (en) TOPIC FORMULATIONS OF NEPAFENAC
UY28126A1 (en) USE OF SELECTIVE GLUCOCORTICOIDS FOR THE EYE SURFACE IN THE TREATMENT OF EYE DROUGHT
CO5390065A1 (en) SOFT CLEANING COMPOSITION THAT HAS STABLE FOAM
WO2002049615A3 (en) Artificial tear composition containing a combination of three demulcents
AR013024A1 (en) DISPOSABLE ABSORBENT ARTICLE THAT HAS A SKIN CARE COMPOSITION CONTAINING AN ENZYME INHIBITOR AND METHOD TO REDUCE ENZYMATIC ACTIVITY.
RU2004111984A (en) METHOD FOR TREATING MIDDLE EAR INFECTIONS
PE20051052A1 (en) NITROOXY DERIVATIVES OF PROSTAGLANDINS
ES2178263T3 (en) OPHTHARMOLOGICAL COMPOSITIONS CONTAINING A CATIONIC GLYCOSIDE AND ANIONIC THERAPEUTIC UNAGENT.
AU2001293851A1 (en) Stabilized hydrogen peroxide solutions
AR035541A1 (en) A TREATMENT METHOD FOR PATIENTS WHO SUFFER FROM SEVERE GLAUCOMA OR NEED A REDUCTION OF INTRAOCULAR PRESSURE (PIO) AND THE USE OF A COMBINATION OF PIO REDUCING AGENTS
AR022099A1 (en) AN OPHTHALMIC COMPOSITION OF SUSTAINED LIBERATION AND A METHOD FOR EYE THERAPY
AR009028A1 (en) PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR PREPARING SUCH COMPOSITIONS AND USE OF SUCH COMPOSITIONS IN THE TREATMENT OF OPHTHALMIC DISEASES AND METHODS FOR TREATING SUCH DISEASES
KR900002789A (en) Method for preserving ophthalmic solution and composition for same
WO2002007731A3 (en) Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma
ECSP982443A (en) COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION
ECSP045387A (en) LIQUID CLEANING COMPOSITION CONTAINING A PRESERVATIVE AND AN EFFECTIVE CHELATING AGENT
ITRM20010438A1 (en) N-ACETYLCISTEIN-BASED OPHTHALMIC PREPARATION FOR THE TREATMENT OF DRY EYE SYNDROME.
AR004077A1 (en) A PARTICULARLY COSMETIC COMPOSITION, AND MORE PARTICULARLY FOR THE PERMANENT DEFORMATION OF KERATINIC FIBERS.
US20140378361A1 (en) Contact lens cleaning compositions
MXPA03010363A (en) Method for treating ocular hypertension and glaucoma.
DE502004010980D1 (en) FOAMABLE COSMETIC CLEANING PREPARATION
ATE227135T1 (en) OPHTHALMIC COMPOSITIONS CONTAINING MIOTIC ACTIVES AND HYPERTONIC ACTIVES